A Neoepitope Subunit Vaccine Targeting the Mutated Estrogen Receptor Ligand Binding Domain to Treat and Prevent Endocrine Resistant ER+ Breast Cancer

Administered By

Awarded By

Contributors

Start/End

  • March 15, 2018 - March 14, 2022